Biotech and Pharmaceuticals Medicine

More

  • Sam Waksal Wants Back In Biotech Tuesday, 17 Mar 2009 | 10:55 AM ET
    Sam Waksal

    Despite my repeated invitations for his first post-jailhouse interview on this blog and through one of his contacts, Sam Waksal didn't respond. Given his Manhattan social scene background it should not, perhaps, come as a surprise that the founder of ImClone Systems decided to have his coming-out party in "New York" magazine.

  • Roche Gets Genentech, But At What Price? Monday, 16 Mar 2009 | 12:56 PM ET

    The overwhelming majority of people who have voted in the “Pharma’s Market” poll about the future of Genentech’s execs and top scientists thinks most of them will eventually bolt.

  • I Can’t Get Off Drugs Monday, 16 Mar 2009 | 11:20 AM ET
    pharma_new3.jpg

    Last week was a busy week, to say the least, on the Pharma beat - So I was looking forward to the weekend and escaping all things drug-related. But as fate would have it, it ended up being bookended by references to pharma in a couple of surprising venues.

  • Dendreon Springs Back To Life Friday, 13 Mar 2009 | 1:52 PM ET

    All of a sudden yesterday and today shares of Dendreon  —my favorite biotech story—shot up on heavy volume.

  • A Lucky Friday The 13th For Merck Friday, 13 Mar 2009 | 10:48 AM ET

    Shares of Dow component Merck rare getting a nice little shot in the arm this morning on an upgrade by Dr. Tim Anderson at Sanford C. Bernstein. He's putting an "Outperform" or "Buy" rating on MRK and raising his target price three bucks to $30.

  • Attention Genentech Employees: Heeeeere's Franz! Thursday, 12 Mar 2009 | 3:29 PM ET

    Only on a day like today when it's wall-to-wall Madoff coverage would a $47 billion deal, the second $40-billion-plus deal to be done in four days, struggle to get some airtime.

  • Can Pfizer's Breakthrough Help Steve Jobs? Thursday, 12 Mar 2009 | 11:27 AM ET
    Apple CEO Steve Jobs introduces the new iPod Nano in San Francisco, Tuesday, Sept. 9, 2008.

    When a press release crosses the wires or pops into the inbox from a Dow component announcing positive late-stage test results on a cancer drug, you rush to get the headlines on the air as quickly as possible.

  • Don't Let The Sun Go Down On Biotech Wednesday, 11 Mar 2009 | 11:03 AM ET
    Elton John

    The Biotechnology Industry Organization just announced that Sir Elton will be the keynote speaker at the 2009 BIO International Convention in Atlanta, the superstar's American hometown.

  • The Genentech Roller Coaster Tuesday, 10 Mar 2009 | 3:34 PM ET
    genetech_logo_new.jpg

    On my Thomson Reuters screen I have the stock quotes of a few dozen of the biopharma companies I cover. Lately, when I glance over at it, there's been a lot of red. With today's market rally, there's a whole lotta green. And that's why the quote in red for Genentech kind of sticks out like a sore thumb.

  • Merck's Dick Clark: I Give Him A 41 Tuesday, 10 Mar 2009 | 10:56 AM ET
    Richard Clark, Merck CEO

    They may have the same name, but America's oldest teenager Dick Clark and Merck's Chairman and CEO Dick Clark appear to have little else in common. One loves the camera, the other not so much.

  • Are You From Jersey?! Big Pharma's From Jersey! Monday, 9 Mar 2009 | 1:00 PM ET
    New Jersey

    New Jersey, where I live and work, is known as "The World's Medicine Chest" or "The Silicon Valley of Pharma."

  • Roche To Genentech: Deal Or No Deal? Friday, 6 Mar 2009 | 3:06 PM ET
    roche_genentech.jpg

    Yeah, "Deal Or No Deal" has become a bit of a tired cliche, but I think it's totally appropriate in the context of the latest salvo in the Roche-Genentech takeover battle.

  • Merck's Jumpin' Januvia Friday, 6 Mar 2009 | 11:10 AM ET

    Japan and Januvia. No, it's not a country—not even a fictional one—even though it sounds like "Genovia" in "The Princess Diaries." It's a diabetes drug from Merck.

  • Pfizer Gets A Two-Fer Thursday, 5 Mar 2009 | 11:20 AM ET
    Pfizer

    As Pfizer Chairman and CEO Jeff Kindler represents at the White House Healthcare Summit today and tries to make the industry's case against government price controls on prescription drugs, a couple of prominent industry analysts are giving him a little something to smile about.

  • Biopharma's Ma & Pa Wednesday, 4 Mar 2009 | 11:52 AM ET
    leerink_swann.jpg

    Forget about mergers and acquisitions (M & A). Think about partnerships and acquisitions or what Leerink Swann, which specializes in healthcare stock coverage, is calling "P & A."

  • Roche Rallies And Genentech Gains Tuesday, 3 Mar 2009 | 11:43 AM ET
    roche_logo.jpg

    The morning after Genentech's big investor meeting shares of the Swiss drugmaker Roche rebounded in overseas trading and the American Despository Receipts that trade over-the-counter here in the States are following suit.

  • Biotech Beats Pfizer Friday, 27 Feb 2009 | 3:33 PM ET

    When I wasn't looking the market value of biotech giant DNA surpassed the market cap of the world's biggest drug company, Pfizer.

  • At Genentech Mum's The Word Friday, 27 Feb 2009 | 1:59 PM ET
    Genetech

    I'm not sure why Genentech isn't responding to Roche's media campaign. Maybe the company's and executives' lawyers are telling them to publicly keep their mouths shut outside of formal presentations like Monday's meeting. Or maybe, for whatever reason, they're decidedly taking a hardline "no media" stance and letting their press releases and SEC filings do all the talkin'.

  • Is Biopharma A "Buy"? Friday, 27 Feb 2009 | 11:46 AM ET
    pharma_new3.jpg

    Even though nearly every analyst this morning is saying Thursday's bloodbath was an overreaction, investors are continuing to sell biopharma stocks in the early going Friday.

  • Big Biotech Bloodbath Thursday, 26 Feb 2009 | 4:49 PM ET

    Today was really ugly for biotech.  The only large-cap sector stock to trade higher--and significantly--was Genentech because it's being bolstered by Roche's bond sale and increasing speculation the Swiss drugmaker is gonna have to raise its bid for DNA.